OpenLegislation

Division 2.1.2.4 Safety of blood, tissues and cells, organs (Annex — points 2.6, 2.7)

United Kingdom

Original text. Later amendments are not shown.

This action aims to promote the quality, safety and availability of substances of human origin (organs, tissues, cells, blood and blood components) used for therapeutic purposes associated with their collection, processing, distribution and use. These activities should help to implement existing EU legislation.

Priority will be given to activities that:

  • develop tools providing practical guidance on risk assessment and validation methodology in procurement, processing, storage and distribution of substances of human origin;

  • conduct a detailed risk assessment of the different types of procedures with the aim of producing specific guidelines for each type of process and substance. They should take into account the type of processing and the route of application of the substances into the human body;

  • gear to promoting voluntary unpaid donations of substances of human origin. Actions should be directed towards sharing data on the routine practices of compensation offered to donors of substances of human origin at hospitals or procurement organisations.

Notes on Division 2.1

Textual amendments

F1

Substituted by Commission Decision of 8 November 2007 amending Decision 2007/102/EC adopting the work plan for 2007 for implementation of the programme of Community action in the field of public health (2003 to 2008), including the annual work programme for grants (Text with EEA relevance) (2007/741/EC).

Footnotes

f1

Commission Decision 2004/858/EC (OJ L 369, 16.12.2004, p. 73).

Notes on Division

Footnotes

f1

Council Decision 2002/834/EC (OJ L 294, 29.10.2002, p. 1). Sixth Framework Programme public health related projects under Scientific Support to Policies — CORDIS web page: http://www.cordis.lu/lifescihealth/ssp.htm

f2

It should be noted that under calls to be published early 2007 under the forthcoming Seventh Framework Programme of the European Community for Research, there will be topics with particular reference to public health in the section ‘Optimising the Delivery of Health Care to European Citizens’.

Notes on Division 2.1.2

Footnotes

f1

Decision No 2119/98/EC of the European Parliament and of the Council. (OJ L 268, 3.10.1998, p. 1).

Commission Decision 2000/57/EC (OJ L 21, 26.1.2000, p. 32).

Commission Decision 2000/96/EC (OJ L 28, 3.2.2000, p. 50).

Commission Decision 2002/253/EC (OJ L 86, 3.4.2002, p. 44).

f2

Regulation (EC) No 851/2004 of the European Parliament and of the Council (OJ L 142, 30.4.2004 p. 1).

f3

See: http://europa.eu/health/ph_threats/Bioterrorisme/bioterrorism01_en.pdf